Skip to main content
Log in

COVID-19 complications

SARS-CoV-2 infection boosts inflammation in atherosclerotic plaques

  • News & Views
  • Published:

From Nature Cardiovascular Research

View current issue Submit your manuscript

The incidence of acute cardiovascular events, including myocardial infarction and ischemic stroke, is increased in individuals with COVID-19. A study shows that SARS-CoV-2 can directly infect macrophages and foam cells in atherosclerotic plaques and contribute to plaque instability.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: SARS-CoV-2 infects coronary vessel lesions.

References

  1. Giacca, M. & Shah, A. M. Nat. Cardiovasc. Res. 1, 200–210 (2022).

    Article  Google Scholar 

  2. Katsoularis, I., Fonseca-Rodriguez, O., Farrington, P., Lindmark, K. & Fors Connolly, A. M. Lancet 398, 599–607 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Shi, S. et al. Eur. Heart J. 41, 2070–2079 (2020).

    Article  CAS  PubMed  Google Scholar 

  4. Shi, S. et al. JAMA Cardiol. 5, 802–810 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lala, A. et al. J. Am. Coll. Cardiol. 76, 533–546 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Eberhardt, N. et al. Nat. Cardiovas. Res. https://doi.org/10.1038/s44161-023-00336-5 (2023).

    Article  Google Scholar 

  7. Bussani, R. et al. J. Pathol. 259, 254–263 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Ackermann, M. et al. N. Engl. J. Med. 383, 120–128 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bussani, R. et al. EBioMedicine 61, 103104 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  10. Braga, L. et al. Nature 594, 8–93 (2021).

    Article  Google Scholar 

  11. Cappelletto, A. et al. Front Cardiovasc. Med. 9, 1013262 (2022).

    Article  CAS  PubMed  Google Scholar 

  12. Lemke, G. Nat. Rev. Immunol. 19, 539–549 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Xie, Y., Xu, E., Bowe, B. & Al-Aly, Z. Nat. Med. 28, 583–590 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zakeri, R. et al. EClinicalMedicine 28, 100574 (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Nafilyan, V. et al. Eur. J. Epidemiol. 36, 605–617 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Work in the Giacca laboratory is supported by the European Research Council (ERC) Advanced Grant 787971 ‘CuRE’; British Heart Foundation (BHF) program grant RG/19/11/34633; King’s College London BHF Centre of Research Excellence grant RE/18/2/34213; grants 825670 ‘CardioReGenix’ and 874764 ‘REANIMA’ from the European Commission Horizon 2020 program.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mauro Giacca.

Ethics declarations

Competing interests

M.G. is founder, consultant, member of the Board and equity holder in Forcefield Therapeutics, Heqet Therapeutics and Purespring Therapeutics.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Giacca, M. SARS-CoV-2 infection boosts inflammation in atherosclerotic plaques. Nat Cardiovasc Res 2, 966–967 (2023). https://doi.org/10.1038/s44161-023-00358-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s44161-023-00358-z

  • Springer Nature Limited

Navigation